Literature DB >> 16679867

Mammography use and factors associated with its use after the introduction of breast cancer screening programmes in Spain.

Setefilla Luengo-Matos1, Mar Polo-Santos, Zuleika Saz-Parkinson.   

Abstract

The aim of this study was to measure the use of mammography and the factors associated with testing among Spanish women, after the introduction of screening programmes in Spain. We conducted a cross-sectional population survey of a representative sample of women aged 40-70 (2409 women). Data collection took place in October 2000, using a questionnaire addressing the dependent variable (mammography use) and the independent variables (socio-demographic and socio-health factors, and women's knowledge and attitudes). Mammography use was defined as having received at least one screening test in the previous 2 years. Data analysis consisted of univariate and multivariate analyses. 48.1% (95% confidence interval (CI) 46.0-50.2) of women had received screening mammography. The main factors associated with testing were: mammography invitation from the screening programme (odds ratio (OR) 4.81; 95% CI 3.85-6.01); gynaecologist visit (OR 4.32; 95% CI 3.45-5.41); and intention to have a mammogram (OR 2.94; 95% CI 2.00-4.32). Other test-related factors were: not rejecting test for discomfort or fear of cancer; mammography perceived as necessary; age 56-65; upper/upper-middle socio-economic status. In conclusion, after the introduction of screening programmes, almost half of Spanish women aged 40-70 had received mammography. Invitation to screening, gynaecologist visit and women's attitudes are the main reasons for undergoing testing. Women over 65 years of age and/or those in a lower socio-economic level warrant special attention.

Entities:  

Mesh:

Year:  2006        PMID: 16679867     DOI: 10.1097/01.cej.0000199503.30818.e6

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  7 in total

1.  Socioeconomic status as determinant for participation in mammography screening: assessing the difference between using women's own versus their partner's.

Authors:  Malin Kjellén; My von Euler-Chelpin
Journal:  Int J Public Health       Date:  2010-03-26       Impact factor: 3.380

2.  Age differences in mammography screening reconsidered: life course trajectories in 13 European countries.

Authors:  Sarah Missinne; Piet Bracke
Journal:  Eur J Public Health       Date:  2014-07-04       Impact factor: 3.367

3.  Socioeconomic disparities in the uptake of breast and cervical cancer screening in Italy: a cross sectional study.

Authors:  Gianfranco Damiani; Bruno Federico; Danila Basso; Alessandra Ronconi; Caterina Bianca Neve Aurora Bianchi; Gian Marco Anzellotti; Gabriella Nasi; Franco Sassi; Walter Ricciardi
Journal:  BMC Public Health       Date:  2012-02-03       Impact factor: 3.295

4.  Cancer screening rate in people with diabetes in the Korean population: results from the Korea National Health and Nutrition Examination Survey 2007-2009.

Authors:  Kumban Walter Chuck; Minji Hwang; Kui Son Choi; Mina Suh; Jae Kwan Jun; Boyoung Park
Journal:  Epidemiol Health       Date:  2017-08-10

5.  Prevalence and predictors of breast and cervical cancer screening among Spanish women with diabetes.

Authors:  Rodrigo Jiménez-Garcia; Valentin Hernandez-Barrera; Pilar Carrasco-Garrido; Angel Gil
Journal:  Diabetes Care       Date:  2009-05-26       Impact factor: 17.152

6.  Identifying specific non-attending groups in breast cancer screening--population-based registry study of participation and socio-demography.

Authors:  Line Flytkjær Jensen; Anette Fischer Pedersen; Berit Andersen; Peter Vedsted
Journal:  BMC Cancer       Date:  2012-11-14       Impact factor: 4.430

7.  Breast cancer screening attendance in two Swiss regions dominated by opportunistic or organized screening.

Authors:  Monika Eichholzer; Aline Richard; Sabine Rohrmann; Seraina M Schmid; Cornelia Leo; Dorothy J Huang; Uwe Güth
Journal:  BMC Health Serv Res       Date:  2016-09-23       Impact factor: 2.655

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.